Literature DB >> 9602695

Increased expression of proliferating cell nuclear antigen in autoimmune hepatitis in a patient with raised serum concentration of CA19-9.

T Sohda1, Y Iwata, H Shijo, Y Egashira, K Egashira, M Okumura.   

Abstract

A 52 year old woman had autoimmune hepatitis and an increased concentration of serum carbohydrate antigen 19-9 (CA19-9). The origin of the raised CA19-9 was studied using immunohistochemistry. Liver biopsy section showed chronic active hepatitis with large numbers of proliferated bile ductules. Immunohistochemical analysis revealed that the proliferated bile ductule cells were positive for proliferating cell nuclear antigen (PCNA) and for CA19-9. It is speculated that the raised serum CA19-9 concentration was derived from proliferated bile ductule cells and these cells, which are positive for PCNA, may be able to produce high concentrations of CA19-9.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602695      PMCID: PMC500516          DOI: 10.1136/jcp.51.2.167

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.

Authors:  A J Czaja; S J Beaver; J R Wood; G G Klee; V L Go
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

2.  Autoimmune hepatitis.

Authors:  I R Mackay; S Weiden; J Hasker
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

3.  Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues.

Authors:  Y Satomura; N Sawabu; Y Takemori; H Ohta; H Watanabe; T Okai; K Watanabe; H Matsuno; F Konishi
Journal:  Pancreas       Date:  1991-07       Impact factor: 3.327

Review 4.  The clinical utility of the CA 19-9 tumor-associated antigen.

Authors:  W Steinberg
Journal:  Am J Gastroenterol       Date:  1990-04       Impact factor: 10.864

5.  Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.

Authors:  W M Steinberg; R Gelfand; K K Anderson; J Glenn; S H Kurtzman; W F Sindelar; P P Toskes
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

6.  Elevated CA19-9 in a case of Mirizzi's syndrome.

Authors:  P S Turtel; I Kreel; J Israel; D Frager; D Berman
Journal:  Am J Gastroenterol       Date:  1992-03       Impact factor: 10.864

7.  Elevated serum levels of tumor marker CA19-9 in acute cholangitis.

Authors:  M B Albert; W M Steinberg; J P Henry
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

8.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

9.  Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.

Authors:  S Kawa; M Tokoo; O Hasebe; K Hayashi; H Imai; H Oguchi; K Kiyosawa; S Furuta; T Homma
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

  9 in total
  1 in total

1.  Elevated tumor markers for monitoring tumor response to immunotherapy.

Authors:  Yi Yang; Xiaolin Jiang; Yun Liu; Huan Huang; Yanli Xiong; He Xiao; Kan Gong; Xuemei Li; Xunjie Kuang; Xueqin Yang
Journal:  EClinicalMedicine       Date:  2022-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.